 Antibodies platelets patients anti-phospholipid antibodies Binding anti-phospholipid antibodies platelets consequences platelet activation aggregation patients anti-phospholipid antibodies patients thrombocytopenia Nine healthy donors controls platelets enzyme-linked immunosorbent assays ELISAs phospholipids antigen platelet eluates Platelet activation flow cytofluorometry monoclonal antibodies activation-specific lysosomal membrane protein Findings ELISA results conventional immunofluorescence method platelet autoantibodies patients antibodies phospholipids present platelet eluates thrombocytopenic patients platelets aggregation impaired positive concordance results immunofluorescence ELISA apparent relation results ELISA immunofluorescence platelet counts anti-phospholipid antibodies platelets binding measurable aggregation abnormalities platelet activation exposure lysosomal membrane proteins studies necessary exact role anti-phospholipid antibodies pathogenesis thrombocytopenia thrombosis